Annika Bergman

1.0k total citations
18 papers, 689 citations indexed

About

Annika Bergman is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Annika Bergman has authored 18 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Annika Bergman's work include BRCA gene mutations in cancer (6 papers), Genomic variations and chromosomal abnormalities (4 papers) and Genetic factors in colorectal cancer (3 papers). Annika Bergman is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Genomic variations and chromosomal abnormalities (4 papers) and Genetic factors in colorectal cancer (3 papers). Annika Bergman collaborates with scholars based in Sweden, United Kingdom and Switzerland. Annika Bergman's co-authors include Margareta Nordling, Tommy Martinsson, Jan Wahlström, Yvonne Engwall, Jan Björk, Lennart Iselius, Rolf Hultcrantz, Per Karlsson, Ajay Patel and Michael Smyth and has published in prestigious journals such as Gastroenterology, PLoS ONE and BMC Medicine.

In The Last Decade

Annika Bergman

17 papers receiving 664 citations

Peers

Annika Bergman

GENET

PFM

SURGE

ONCOL

PRM

Sarah Ingham United Kingdom

Jessica N. Everett United States

Sarah Scollon United States

Shanna Gustafson United States

Rose B. McGee United States

Corey Pelletier United States

Robin A. Lacour United States

Emily Glogowski United States

Deborah A. McDermott United States

Julian Barwell United Kingdom

Sarah Ingham United Kingdom

Annika Bergman

325 ×1.5

GENET

103 ×0.5

PFM

149 ×1.0

SURGE

250 ×1.7

ONCOL

113 ×1.0

PRM

Citations per year, relative to Annika Bergman Annika Bergman (= 1×) peers Sarah Ingham

Countries citing papers authored by Annika Bergman

Since Specialization

Citations

This map shows the geographic impact of Annika Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Bergman more than expected).

Fields of papers citing papers by Annika Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Bergman. The network helps show where Annika Bergman may publish in the future.

Co-authorship network of co-authors of Annika Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Bergman. A scholar is included among the top collaborators of Annika Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Bergman. Annika Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wilson, Michele, et al.. (2017). Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. The European Journal of Health Economics. 19(2). 229–240. 27 indexed citations

Ainsworth, Claire, et al.. (2016). Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis. PLoS ONE. 11(10). e0165435–e0165435. 82 indexed citations

Patel, Ajay, et al.. (2013). The Economic Burden of Complications Occurring in Major Surgical Procedures: a Systematic Review. Applied Health Economics and Health Policy. 11(6). 577–592. 63 indexed citations

Findley, Leslie J., et al.. (2011). The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset. Journal of Medical Economics. 14(1). 130–139. 57 indexed citations

Lowin, Julia, Annika Bergman, К. Ray Chaudhuri, et al.. (2011). A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK. Journal of Medical Economics. 14(5). 584–593. 40 indexed citations

Thorell, Kaisa, Annika Bergman, Helena Carén, et al.. (2009). Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes. BMC Medical Genomics. 2(1). 53–53. 22 indexed citations

Bergman, Annika, Pelle Sahlin, Monica Emanuelsson, et al.. (2009). Germline mutation screening of the Saethre-Chotzen-associated genesTWIST1andFGFR3in families withBRCA1/2-negative breast cancer. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 43(5). 251–255. 1 indexed citations

Bergman, Annika, Pelle Sahlin, Monica Emanuelsson, et al.. (2009). Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 1–5.

Kanter-Smoler, Gunilla, Anna Rohlin, Yvonne Engwall, et al.. (2008). Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Medicine. 6(1). 10–10. 36 indexed citations

10.

Bergman, Annika, Frida Abel, Afrouz Behboudi, et al.. (2008). No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2in familial breast cancer with linkage to 19p. BMC Medical Genetics. 9(1). 12 indexed citations

11.

Bergman, Annika. (2007). Co-Constitution of Domestic and International Welfare Obligations. Cooperation and Conflict. 42(1). 73–99. 46 indexed citations

12.

Bergman, Annika, Per Karlsson, Tommy Martinsson, et al.. (2006). Genome‐wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non‐BRCA1/2 families: Suggestive linkage to 10q23.32‐q25.3. Genes Chromosomes and Cancer. 46(3). 302–309. 16 indexed citations

13.

Einbeigi, Zakaria, Annika Bergman, Jeanne M. Meis‐Kindblom, et al.. (2006). Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden. Familial Cancer. 6(1). 35–41. 12 indexed citations

14.

Bergman, Annika. (2006). Adjacent Internationalism. Cooperation and Conflict. 41(1). 73–97. 21 indexed citations

15.

Bergman, Annika, Yvonne Engwall, Eva Lagberg Arkblad, et al.. (2005). A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques. Familial Cancer. 4(2). 89–96. 25 indexed citations

16.

Vujic, Mihailo, Annika Bergman, B. Romanus, Jan Wahlström, & Tommy Martinsson. (2004). Hereditary multiple and isolated sporadic exostoses in the same kindred: Identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes. International Journal of Molecular Medicine. 13(1). 47–52. 5 indexed citations

17.

Björk, Jan, Lennart Iselius, Annika Bergman, et al.. (2001). Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations. Gastroenterology. 121(5). 1127–1135. 174 indexed citations

18.

Bergman, Annika, Zakaria Einbeigi, Arne Wallgren, et al.. (2001). The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. European Journal of Human Genetics. 9(10). 787–793. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact